BiotherapyVideo
Categories
- Allergy
- Alzheimer's Disease
- Arthritis
- Asthma
- Breast Cancer
- Cardio Health
- Cholesterol
- Cold and Flu
- Colon Cancer
- Diabetes
- Dieting
- Epilepsy
- Hair Loss
- Headache
- Heartburn
- HIV & AIDS
- Kidney Health
- Leukemia
- Lung Cancer
- Lymphoma
- Multiple Sclerosis
- Men's Health
- Mental Health
- Nutrition
- Osteoporosis
- Parkinson's Disease
- Prostate Health
- Skin Health
- Sleep Disorders
- Women's Health
- General
Imaging Advance Tracks Prostate Cancer in Lymph Nodes
Posted on 07/15/2008, 17:00
By --HealthDay staff
Engineered 'payload' based on common cold virus could aid doctors in treatment decisions
TUESDAY, July 15 (HealthDay News) -- A new imaging technique, based on an engineered version of the common cold virus, may help doctors detect the spread of prostate cancer to the lymph nodes earlier.
This, in turn, could help guide more effective treatment decisions, said the authors of a study published in the July 11 edition of Nature Medicine.
"It would represent a treatment advance in patients for whom outcome is not good," study senior author Dr. Lily Wu, a researcher at UCLA's Jonsson Cancer Center, said in a university news release. "This would help improve the prognosis for these patients by letting us find and treat these metastases early. If we can catch the cancer before it invades other organs, we have a better chance to change the outcomes for these patients."
Patients whose prostate cancer has traveled to their lymph nodes are more likely to have a recurrence. Finding these tiny metastases in the pelvic lymph nodes is key to making future treatment decisions, yet it is also supremely difficult to do with conventional imaging techniques.
Wu and her colleagues engineered a common cold virus armed with a specific "genetic payload" to travel directly to lymph nodes in mice and to express its payload only in prostate cells.
The payload consists of a protein that can be picked up on PET scans.
Wu and her colleagues next want to combine the imaging technique with treatment, so that a drug contained in the genetic payload could kill the traveling tumor cells.
"I think this is very exciting for many reasons," said Wu. "We now know we can reach these prostate cancer metastases at an earlier stage than before, and we know we can deliver genes to those cancer cells that produce proteins that can be imaged by PET. Now we will find out how effective this genetic toxic payload is in preventing further spread of the cancer to other vital organs."
More information
Visit the National Cancer Institute for more on prostate cancer.
SOURCE: University of California, Los Angeles, news release, July 11, 2008
Copyright © 2008 ScoutNews, LLC. All rights reserved.
More news in Prostate Health...
BigHealthTree.com Disclaimer
Bighealthtree.com Does Not Provide Medical Advice. This site, including the above information, is for informational purposes only and is not a substitute for professional medical or health advice. Always seek the advice of your physician or a qualified health or medical professional before starting any new treatment, changing existing treatment, or altering your current exercise and/or diet program. If you think you are having a medical emergency, call 911 (or the emergency services in your area) or your doctor immediately.
Prenatal Alcohol
Ovarian Cancer
Fire Safe Cigarettes
Christmas Colonoscopy
ER Doctors
Colonoscopy Study
Carbon Monoxide Family
Busting Diet Myths
Holiday Eating
Colon Cancer Race
Yoga and Stress
Fast Food
In the Dark
Sleep Meds

Comments (0):
Be the first to comment on this article.
Post a comment